Kristin S Weeks1,2, Charles F Lynch2,3, Michele West3, Megan McDonald4, Ryan Carnahan2, Sherri L Stewart5, Mary Charlton2,3. 1. Carver College of Medicine, University of Iowa, Iowa City, Iowa. 2. Department of Epidemiology, University of Iowa, Iowa City, Iowa. 3. Iowa Cancer Registry, State Health Registry of Iowa, University of Iowa, Iowa City, Iowa. 4. Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Iowa Hospitals and Clinics, Iowa City, Iowa. 5. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.
Abstract
PURPOSE: We aim to understand if rurality impacts patients' odds of presenting with stage IV ovarian cancer at diagnosis independent of distance to primary care provider and the socioeconomic status of a patient's residential census tract. METHODS: A cohort of 1,000 women with ovarian cancer in Iowa, Kansas, and Missouri were sampled and analyzed from the cancer registries' statewide population data. The sample contained those with a histologically confirmed primary ovarian cancer diagnosis in 2011-2012. All variables were captured through an extension of standard registry protocol using standardized definitions and abstraction manuals. Chi-square tests and a multivariable logistic regression model were used. FINDINGS: At diagnosis, 111 women in our sample had stage IV cancer and 889 had stage I-III. Compared to patients with stage I-III cancer, patients with stage IV disease had a higher average age, more comorbidities, and were more often living in rural areas. Multivariate analysis showed that rural women (vs metropolitan) had a greater odds of having stage IV ovarian cancer at diagnosis (odds ratio = 2.41 and 95% confidence interval = 1.33-4.39). CONCLUSION: Rural ovarian cancer patients have greater odds of having stage IV cancer at diagnosis in Midwestern states independent of the distance they lived from their primary care physician and the socioeconomic status of their residential census tract. Rural women's greater odds of stage IV cancer at diagnosis could affect treatment options and mortality. Further investigation is needed into reasons for these findings.
PURPOSE: We aim to understand if rurality impacts patients' odds of presenting with stage IV ovarian cancer at diagnosis independent of distance to primary care provider and the socioeconomic status of a patient's residential census tract. METHODS: A cohort of 1,000 women with ovarian cancer in Iowa, Kansas, and Missouri were sampled and analyzed from the cancer registries' statewide population data. The sample contained those with a histologically confirmed primary ovarian cancer diagnosis in 2011-2012. All variables were captured through an extension of standard registry protocol using standardized definitions and abstraction manuals. Chi-square tests and a multivariable logistic regression model were used. FINDINGS: At diagnosis, 111 women in our sample had stage IV cancer and 889 had stage I-III. Compared to patients with stage I-III cancer, patients with stage IV disease had a higher average age, more comorbidities, and were more often living in rural areas. Multivariate analysis showed that rural women (vs metropolitan) had a greater odds of having stage IV ovarian cancer at diagnosis (odds ratio = 2.41 and 95% confidence interval = 1.33-4.39). CONCLUSION: Rural ovarian cancer patients have greater odds of having stage IV cancer at diagnosis in Midwestern states independent of the distance they lived from their primary care physician and the socioeconomic status of their residential census tract. Rural women's greater odds of stage IV cancer at diagnosis could affect treatment options and mortality. Further investigation is needed into reasons for these findings.
Authors: S Dey; A Hablas; I A Seifeldin; K Ismail; M Ramadan; H El-Hamzawy; M L Wilson; M Banerjee; P Boffetta; J Harford; S D Merajver; A S Soliman Journal: BJOG Date: 2009-12-16 Impact factor: 6.531
Authors: Dragana Radovanovic; Burkhardt Seifert; Philip Urban; Franz R Eberli; Hans Rickli; Osmund Bertel; Milo A Puhan; Paul Erne Journal: Heart Date: 2013-11-01 Impact factor: 5.994
Authors: Hannah L Conley; C Suzanne Lea; Raven V Delgado; Paul Vos; Eleanor E Harris; Andrew Ju; Kimberly M Rathbun Journal: J Racial Ethn Health Disparities Date: 2022-10-10
Authors: Keely Krolikowski Ulmer; Breanna Greteman; Nicholas Cardillo; Anthony Schneider; Megan McDonald; David Bender; Michael J Goodheart; Jesus Gonzalez Bosquet Journal: Int J Gynecol Cancer Date: 2022-04-04 Impact factor: 4.661
Authors: Keely K Ulmer; Breanna Greteman; Megan McDonald; Jesus Gonzalez Bosquet; Mary E Charlton; Sarah Nash Journal: Womens Health Rep (New Rochelle) Date: 2022-08-04
Authors: Abigail S Zamorano; Angela L Mazul; Christine Marx; Mary M Mullen; Molly Greenwade; L Stewart Massad; Carolyn K McCourt; Andrea R Hagemann; Premal H Thaker; Katherine C Fuh; Matthew A Powell; David G Mutch; Dineo Khabele; Lindsay M Kuroki Journal: Gynecol Oncol Rep Date: 2022-10-03